Related Experiment Videos
Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk
R D Dickerman1, W J McConathy, N Y Zachariah
1Department of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth 76107-2699, USA.
Insights
Anabolic steroid use in bodybuilders lowered LDL cholesterol and triglycerides but increased the total:HDL cholesterol ratio. This challenges the direct role of androgens in cardiovascular disease risk.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Sports Medicine
Background:
- Men's higher risk of coronary heart disease is linked to testosterone.
- Androgens affect lipoprotein levels, potentially increasing cardiovascular disease risk.
- Anabolic steroid abuse in bodybuilders raises concerns about cardiovascular risk.
Purpose of the Study:
- To assess cardiovascular risks in anabolic steroid-using bodybuilders.
- To compare lipid and apolipoprotein levels between steroid users and drug-free bodybuilders.
Main Methods:
- Recruited 12 competitive bodybuilders (6 steroid users, 6 drug-free).
- Measured testosterone, sex hormone-binding globulin, total cholesterol, HDL, LDL, triglycerides, apolipoproteins A-I and B.
- Assessed cardiovascular risk factors in both groups.
Main Results:
- Steroid group had lower total, HDL, LDL cholesterol, apolipoproteins A-I and B, and triglycerides.
- Steroid group had higher testosterone and lower sex hormone-binding globulin.
- Steroid group exhibited a significantly higher total:HDL cholesterol ratio.
Conclusions:
- Androgens decreased HDL cholesterol and apolipoprotein A-I, as expected.
- Androgens also reduced LDL cholesterol and apolipoprotein B.
- Low total cholesterol and triglycerides in steroid users question the direct role of androgens in cardiovascular disease risk despite a higher total:HDL ratio.
Background:
That men have a higher risk of coronary heart disease has implicated testosterone as a risk factor. Lipoprotein levels have been reported to be altered by androgens, thus increasing the risk of coronary heart disease, myocardial infarction, and sudden death. The increasing abuse of anabolic steroids and reports of cases of sudden death and myocardial infarction among bodybuilders have raised concerns about an increase in cardiovascular risk for this population.
Methods:
Twelve competitive bodybuilders were recruited for a comprehensive study on the cardiovascular risks associated with use of anabolic steroids. Six competitive heavyweight bodybuilders ingesting self-directed regimens of anabolic steroids (steroid group) and six competitive heavyweight drug-free bodybuilders were used for cardiovascular risk assessment. Apolipoproteins A-I and B, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglyceride, testosterone, and sex hormone-binding globulin levels were determined in each athlete.
Results:
Total, HDL and LDL cholesterol, apolipoproteins A-I and B, and triglyceride levels were significantly lower in members of the steroid group. As expected, testosterone level was significantly higher in members of the steroid group; sex hormone-binding globulin level was significantly lower. Apolipoprotein and lipoprotein levels were lower in members of the steroid group, whereas the total: HDL cholesterol ratio was significantly higher for members of the steroid group.
Conclusions:
Consistently with previous reports, androgens were associated with decreases in HDL cholesterol and apolipoprotein A-I levels. However, androgens were also associated with reduced LDL cholesterol and apolipoprotein B levels. Despite the significantly higher total: HDL cholesterol ratio, the low serum total cholesterol levels (within the fifth percentile) and low plasma triglyceride levels in members of the steroid group raise questions concerning the exact role of androgens in increasing risk of cardiovascular disease.